• Je něco špatně v tomto záznamu ?

Cytokine cascade in Kawasaki disease versus Kawasaki-like syndrome

MA. Bordea, C. Costache, A. Grama, AI. Florian, I. Lupan, G. Samasca, D. Deleanu, P. Makovicky, P. Makovicky, K. Rimarova

. 2022 ; 71 (1) : 17-27. [pub] 20220119

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22009491

Kawasaki disease (KD) is a medium vessel systemic vasculitis that predominantly occurs in children below five years of age. It is an acute febrile condition in which coronary artery aneurysms and myocarditis are the most common cardiovascular complications. It is most often characterized by hypercytokinemia. The etiopathogenesis of KD is not fully understood. The present review synthesizes the recent advances in the pathophysiology and treatment options of KD. According to different studies, the genetic, infections and autoimmunity factors play a major role in pathogenesis. Several susceptibility genes (e.g. caspase 3) and cytokines (e.g. IL-2, IL-4, IL-6, IL-10, IFN-gamma and TNF-alpha) have been identified in KD. Patients with high cytokine levels are predisposed to KD shock syndrome. The importance of respiratory viruses in the pathogenesis of the disease is unclear. Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may induce in children and adults an abnormal systemic inflammatory response. This syndrome shares characteristics with KD. It has been called by many terms like MIS-C (Multisystem Inflammatory Syndrome in Children), PIMS-TS (pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2), hyperinflammatory shock syndrome, cytokine storm (cytokine release syndrome) or simply, Kawasaki-like syndrome. The cytokine's role in the development of KD or Kawasaki-like syndrome being triggered by COVID-19 is controversial. The presences of the antiendothelial cell autoantibodies (AECAs) together with the newly developed hypothesis of immunothrombosis are considered potential pathogenic mechanisms for KD. In consequence, the diagnosis and treatment of KD and Kawasaki-like syndrome, one of the most common causes of acquired heart disease in developed countries, are challenging without a clearly defined protocol.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22009491
003      
CZ-PrNML
005      
20230331091401.0
007      
ta
008      
220419s2022 xr f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934672 $2 doi
035    __
$a (PubMed)35043641
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Bordea, Mădălina Adriana $u Emergency Hospital for Children, Cluj-Napoca, Romania $u Department of Microbiology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
245    10
$a Cytokine cascade in Kawasaki disease versus Kawasaki-like syndrome / $c MA. Bordea, C. Costache, A. Grama, AI. Florian, I. Lupan, G. Samasca, D. Deleanu, P. Makovicky, P. Makovicky, K. Rimarova
520    9_
$a Kawasaki disease (KD) is a medium vessel systemic vasculitis that predominantly occurs in children below five years of age. It is an acute febrile condition in which coronary artery aneurysms and myocarditis are the most common cardiovascular complications. It is most often characterized by hypercytokinemia. The etiopathogenesis of KD is not fully understood. The present review synthesizes the recent advances in the pathophysiology and treatment options of KD. According to different studies, the genetic, infections and autoimmunity factors play a major role in pathogenesis. Several susceptibility genes (e.g. caspase 3) and cytokines (e.g. IL-2, IL-4, IL-6, IL-10, IFN-gamma and TNF-alpha) have been identified in KD. Patients with high cytokine levels are predisposed to KD shock syndrome. The importance of respiratory viruses in the pathogenesis of the disease is unclear. Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may induce in children and adults an abnormal systemic inflammatory response. This syndrome shares characteristics with KD. It has been called by many terms like MIS-C (Multisystem Inflammatory Syndrome in Children), PIMS-TS (pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2), hyperinflammatory shock syndrome, cytokine storm (cytokine release syndrome) or simply, Kawasaki-like syndrome. The cytokine's role in the development of KD or Kawasaki-like syndrome being triggered by COVID-19 is controversial. The presences of the antiendothelial cell autoantibodies (AECAs) together with the newly developed hypothesis of immunothrombosis are considered potential pathogenic mechanisms for KD. In consequence, the diagnosis and treatment of KD and Kawasaki-like syndrome, one of the most common causes of acquired heart disease in developed countries, are challenging without a clearly defined protocol.
650    12
$a COVID-19 $x komplikace $7 D000086382
650    _2
$a dítě $7 D002648
650    _2
$a cytokiny $7 D016207
650    _2
$a lidé $7 D006801
650    12
$a Kawasakiho syndrom $x komplikace $x diagnóza $x terapie $7 D009080
650    _2
$a SARS-CoV-2 $7 D000086402
650    _2
$a syndrom systémové zánětlivé reakce $7 D018746
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Costache, Carmen $u Department of Microbiology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
700    1_
$a Grama, Alina $u Emergency Hospital for Children, Cluj-Napoca, Romania
700    1_
$a Florian, Alexandru Ioan $u Department of Neuroscience, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
700    1_
$a Lupan, Iulia $u Department of Molecular Biology, Babes Bolyai University, Cluj-Napoca, Romania
700    1_
$a Samasca, Gabriel $u Department of Immunology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
700    1_
$a Deleanu, Diana $u Department of Immunology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
700    1_
$a Makovický, Peter, $d 1978- $7 xx0081652 $u Cancer Research Institute, Biomedical Research Centre of the Slovak Academy of Sciences, Bratislava, Slovak Republic $u Department of Histology and Embryology, Faculty of Medicine, University of Ostrava, Czech Republic
700    1_
$a Makovický, Pavol $7 xx0228426 $u Department of Biology, Faculty of Education, J. Selye University, Komárno, Slovak Republic
700    1_
$a Rimárová, Kvetoslava, $d 1958- $7 xx0224806 $u Department of Public Health and Hygiene, Faculty of Medicine, P. J. Šafárik University, Košice, Slovak Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 71, č. 1 (2022), s. 17-27
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35043641 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20220419 $b ABA008
991    __
$a 20230331091356 $b ABA008
999    __
$a ok $b bmc $g 1796999 $s 1160689
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 71 $c 1 $d 17-27 $e 20220119 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK198 $a Pubmed-20220419

Najít záznam

Citační ukazatele

Možnosti archivace